SPL Set ID: f34c4504-5409-406e-995b-138e5f700242
1 drug(s) with this SPL Set ID
Divalproex sodium, USP is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium has the following structure: Divalproex sodium, USP occurs as a white to off-white powder. Divalproex sodium delayed-release capsules, USP are for oral administration. Divalproex sodium delayed-release capsules, USP contain specially coated particles of divalproex sodium, USP equivalent to 125 mg of valproic acid in a hard gelatin capsule. Inactive Ingredients Divalproex sodium delayed-release capsules USP, 125 mg: sugar spheres (composed of sucrose, corn starch and water), ethyl cellulose, magnesium stearate, triethyl citrate and hypromellose. Hard gelatin capsule shell contains gelatin, titanium dioxide, FD&C Blue No.1 and D&C Red No. 28. The capsule shells are printed with edible black ink containing shellac, black iron oxide and potassium hydroxide. Meets USP Dissolution Test 2. divalproex-structure.jpg